{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-053328","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2026-08-05T20:07:17+00:00","discovered_at":"2026-08-05T20:08:00.245896+00:00","generated_at":"2026-08-05T20:08:24.404056+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"agilon health Q2 net income $18M vs loss; raises FY2026 guidance","bullets":["Total revenue $1.49B (+7% YoY); net income $18M vs net loss $104M in Q2 2025.","Medical margin $197M vs negative $53M; Adjusted EBITDA $70M vs negative $83M.","Total members 549,000 (down 10% YoY) due to disciplined contracting and market exits.","FY2026 guidance raised: revenue $5,775-$5,860M, medical margin $465-$505M, Adj. EBITDA $75-$95M.","Q3 2026 guidance: revenue $1,445-$1,475M, medical margin $105-$115M, Adj. EBITDA ($5)-$5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-053328","json":"https://secwatch.observer/filing/0001628280-26-053328.json","markdown":"https://secwatch.observer/filing/0001628280-26-053328.md","text":"https://secwatch.observer/filing/0001628280-26-053328.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828026053328/0001628280-26-053328-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828026053328/agl-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:08:24.404056+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}